CFDA-SE
Based on 107 publication(s) in Google Scholar
CFDA-SE is a fluorescent dye that can penetrate the cell membrane. It can react with the free amine group in the cytoskeleton protein inside the cell, and finally form a protein complex with fluorescence. After entering the cell, CFDA-SE locates in the cell membrane, cytoplasm and nucleus, and the fluorescence staining is strongest in the nucleus. CFDA-SE dye can be uniformly inherited by the cells with cell division and proliferation, and its attenuation is proportional to the number of cell divisions. This phenomenon can be detected and analyzed by flow cytometry under the excitation light of 488 nm, and can be used to detect the proliferation of cells.
For research use only. We do not sell to patients.
- Purity: 97.0%
- CAS No.: 150347-59-4
- Formula: C29H19NO11
- Molecular Weight:557.46
-
Storage:
-20°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications Citing Use of MedChemExpress (MCE) CFDA-SE
More- Signal Transduct Target Ther. 2024 Feb 28;9(1):43. [Abstract]
- Signal Transduct Target Ther. 2024 Apr 5;9(1):84. [Abstract]
- Nat Cancer. 2020 Feb;1(2):222-234. [Abstract]
- Nat Immunol. 2025 Mar;26(3):391-403. [Abstract]
- Adv Mater. 2023 Nov;35(46):e2303614. [Abstract]
- Cell Res. 2023 Jun;33(6):464-478. [Abstract]
- Bioact Mater. 2026 Feb 4:60:607-625. [Abstract]
- Adv Funct Mater. 2023 May 14.
- ACS Nano. 2025 Aug 29. [Abstract]
- ACS Nano. 2024 Oct 15;18(41):28038-28051. [Abstract]
- Nat Commun. 2026 Feb 9;17(1):1441. [Abstract]
- Autophagy. 2021 Nov;17(11):3592-3606. [Abstract]
- Theranostics. 2021 Feb 20;11(9):4251-4261. [Abstract]
- J Adv Res. 2025 Mar 17:S2090-1232(25)00186-9. [Abstract]
- Biomaterials. 2024 Dec:311:122672. [Abstract]
- Small. 2025 Aug 13:e01291. [Abstract]
- Gut Microbes. 2024 Jan-Dec;16(1):2313770. [Abstract]
- Gut Microbes. 2023 Dec;15(2):2249143. [Abstract]
- Cell Rep Med. 2025 Apr 25:102098. [Abstract]
- J Immunother Cancer. 2025 Jun 3;13(6):e010873. [Abstract]
- Cell Rep Med. 2024 May 16:101580. [Abstract]
- Pharmacol Res. 2025 Mar 31:107721. [Abstract]
- Cancer Lett. 2024 Apr 10:587:216732. [Abstract]
- Cancer Lett. 2023 Jun 28:564:216208. [Abstract]
- Cancer Lett. 2022 Aug 10:541:215746. [Abstract]
- Acta Biomater. 2025 Jun 1:199:346-360. [Abstract]
- Cell Death Dis. 2025 May 14;16(1):380. [Abstract]
- Cell Death Dis. 2025 Jan 26;16(1):43. [Abstract]
- Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2201899119. [Abstract]
- J Pharm Anal. 2024 Jun;14(6):100926. [Abstract]
- Dev Cell. 2025 Jun 23;60(12):1669-1685.e6. [Abstract]
- Int J Biol Macromol. 2025 Oct 14;330(Pt 4):148307. [Abstract]
- Int J Biol Macromol. 2024 Aug;275(Pt 1):133453. [Abstract]
- Phytomedicine. 2025 Oct 21:148:157439. [Abstract]
- Free Radic Biol Med. 2025 Dec 24:245:18-29. [Abstract]
- J Transl Med. 2025 May 14;23(1):540. [Abstract]
- Oncogene. 2023 Sep;42(38):2841-2853. [Abstract]
- J Med Chem. 2025 Feb 27;68(4):4352-4372. [Abstract]
- Neural Regen Res. 2024 Oct 1;19(10):2259-2269. [Abstract]
- NPJ Vaccines. 2025 Jan 3;10(1):1. [Abstract]
- OncoImmunology. 2022 Feb 1;11(1):2032918. [Abstract]
- J Agric Food Chem. 2025 Sep 3;73(35):21976-21986. [Abstract]
- J Agric Food Chem. 2025 Jan 8;73(1):549-561. [Abstract]
- Eur J Med Chem. 2025 May 29:295:117798. [Abstract]
- Front Immunol. 2021 Mar 9;12:637335. [Abstract]
- Chin Med. 2026 Feb 3;21(1):64. [Abstract]
- Colloids Surf B Biointerfaces. 2025 Jun 24:255:114898. [Abstract]
- Biochem Pharmacol. 2025 Mar 29:116912. [Abstract]
- J Ethnopharmacol. 2025 Sep 23;355(Pt A):120635. [Abstract]
- Cells. 2025 Nov 25;14(23):1856. [Abstract]
- Int J Pharm. 2024 Jun 10:124332. [Abstract]
- Int J Pharm. 2022 Jul 25:623:121910. [Abstract]
- Liver Int. 2020 Jan;40(1):131-140. [Abstract]
- J Pharm Investig. 2025 Dec 15.
- Commun Biol. 2023 Jun 1;6(1):592. [Abstract]
- Life Sci. 2020 Dec 1;262:118565. [Abstract]
- PLoS Pathog. 2026 Mar 10;22(3):e1013968. [Abstract]
- Front Pharmacol. 2024 Aug 23:15:1419390. [Abstract]
- Pharm Biol. 2023 Dec;61(1):918-926. [Abstract]
- Pharmaceuticals. 2022 Aug 26;15(9):1059. [Abstract]
- Pharmaceuticals (Basel). 2022 Mar 10;15(3):338. [Abstract]
- Front Bioeng Biotechnol. 2021 Sep 6;9:739209. [Abstract]
- Cell Oncol (Dordr). 2020 Dec;43(6):1099-1116. [Abstract]
- Int Immunopharmacol. 2026 May 15:177:116529. [Abstract]
- Int Immunopharmacol. 2025 Nov 17;168(Pt 2):115848. [Abstract]
- Int Immunopharmacol. 2025 Sep 10:165:115526. [Abstract]
- Int Immunopharmacol. 2025 May 15:158:114835. [Abstract]
- Int Immunopharmacol. 2021 Nov:100:108096. [Abstract]
- Mol Ther Methods Clin Dev. 2021 Jun 11:21:754-764. [Abstract]
- RSC Adv. 2020 Apr 6;10(23):13848-13854. [Abstract]
- Cancer Biol Ther. 2020 Jul 2;21(7):597-603. [Abstract]
- Hepatobiliary Pancreat Dis Int. 2020 Jun;19(3):235-243. [Abstract]
- Eur J Pharm Biopharm. 2022 Dec:181:36-48. [Abstract]
- Front Cell Dev Biol. 2022 Apr 20;10:889656. [Abstract]
- FEBS J. 2025 Nov 27. [Abstract]
- Mol Nutr Food Res. 2022 Jan;66(2):e2100619. [Abstract]
- J Cell Mol Med. 2021 Jul;25(14):7052-7065. [Abstract]
- J Cell Mol Med. 2021 Jun;25(12):5586-5601. [Abstract]
- J Inflamm Res. 2025 Mar 10:18:3469-3484. [Abstract]
- Transl Oncol. 2025 Apr:54:102322. [Abstract]
- iScience. 2024 Mar 16;27(4):109502. [Abstract]
- Transl Oncol. 2024 Feb:40:101831. [Abstract]
- iScience. 2023 Sep 9;26(10):107884. [Abstract]
- iScience. 2023 Feb 16;26(3):106221. [Abstract]
- Sci Rep. 2025 Aug 19;15(1):30411. [Abstract]
- ACS Infect Dis. 2022 Dec 9;8(12):2464-2479. [Abstract]
- Mol Cell Biochem. 2026 Mar 13. [Abstract]
- Heliyon. 2023 Mar 21;9(4):e14655. [Abstract]
- Microb Pathog. 2025 Mar 21:107472. [Abstract]
- Vaccines. 2025 Mar 19;13(3):324. [Abstract]
- BMC Cancer. 2021 Oct 13;21(1):1101. [Abstract]
- Cytotherapy. 2025 Dec;27(12):1419-1426. [Abstract]
- J Leukoc Biol. 2023 Sep 1;114(3):266-279. [Abstract]
- Immunopharmacol Immunotoxicol. 2020 Feb;42(1):28-36. [Abstract]
- J Cancer Res Clin Oncol. 2023 Jul;149(7):3495-3511. [Abstract]
- Ther Adv Chronic Dis. 2021 Apr 27:12:2040622321991705. [Abstract]
- Animals (Basel). 2026 Feb 3;16(3):471. [Abstract]
- Cent Eur J Immunol. 2022;47(2):125-138. [Abstract]
- SSRN. 2025 Apr 4.
- SSRN. 2024 Nov 12.
- J Tradit Chinese Medical Sci. 2024 Sep 3.
- bioRxiv. 2024 August 10.
- Research Square Preprint. 2023 Dec 28.
- Research Square Print. 2023 Mar 1.
- Research Square Print. September 27th, 2022.
- Dis Markers. 2021 Oct 15;2021:5838582. [Abstract]
- SSRN. 22 Jun 2021.
-
Flow Cytometry
-
Cell Proliferation/Viability Assay
-
Cell Proliferation/Viability Assay
-
Cell Proliferation/Viability Assay
-
In Vivo Imaging
Biological Activity
Guide (The following is our recommended experimental protocol. This protocol is for reference only and should be modified according to your specific needs).
Preparation of CFDA-SE working solution
1.1 Preparation of the stock solution
Dissolve 1 mg of CFDA-SE in 0.1794 mL of DMSO to obtain 10 mM of CFSE.
Note: It is recommended to store the stock solution at -20°C or -80°C away from light and avoid repetitive freeze-thaw cycles.
1.2 Preparation of CFDA-SE working solution
Dilute the stock solution in serum-free cell culture medium or PBS to obtain 5-10 μM of CFDA-SE working solution.
Note: Please adjust the concentration of CFDA-SE working solution according to the actual situation.
Cell staining
2.1 For suspension cells: Centrifuge at 1000 g at 4°C for 3-5 minutes and then discard the supernatant. Wash twice with PBS, 5 minutes each time.
For adherent cells: Discard the cell culture medium, and add trypsin to dissociate cells to make a single-cell suspension. Centrifuge at 1000 g at 4°C for 3-5 minutes and then discard the supernatant. Wash twice with PBS, 5 minutes each time.
2.2 Add 1 mL of CFDA-SE working solution, and then incubate at room temperature for 30 minutes.
2.3 Centrifuge at 400 g at 4°C for 3-4 minutes and then discard the supernatant.
2.4 Wash twice with PBS, 5 minutes each time.
2.5 Resuspend cells with serum-free cell culture medium or PBS, and then detect by fluorescence microscope or flow cytometer.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
515
485
Chemical Information
-
CAS No. 150347-59-4
-
Appearance Solid
-
Molecular Weight 557.46
-
Formula C29H19NO11
-
Color Off-white to yellow
-
SMILES
CC(OC1=CC=C(C2(C(C=CC(C(ON3C(CCC3=O)=O)=O)=C4)=C4C(O2)=O)C(C=CC(OC(C)=O)=C5)=C5O6)C6=C1)=O.CC(OC7=CC=C(C8(C(C=C(C(ON9C(CCC9=O)=O)=O)C=C%10)=C%10C(O8)=O)C(C=CC(OC(C)=O)=C%11)=C%11O%12)C%12=C7)=O
-
Synonyms
CFSE; 5(6)-Carboxyfluorescein diacetate succinimidyl ester; 5(6)-CFDA N-succinmidyl ester
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications (107)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
2024 Feb 28;9(1):43. PMID: 38413575 -
Signal Transduct Target Ther
Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis. [Abstract]2024 Apr 5;9(1):84. PMID: 38575583 -
Nat Cancer
MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination. [Abstract]2020 Feb;1(2):222-234. PMID: 35122005 -
Nat Immunol
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer. [Abstract]2025 Mar;26(3):391-403. PMID: 39905201 -
Adv Mater
Esterase-Labile Quaternium Lipidoid Enabling Improved mRNA-LNP Stability and Spleen-Selective mRNA Transfection. [Abstract]2023 Nov;35(46):e2303614. PMID: 37490011 -
Cell Res
SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches. [Abstract]2023 Jun;33(6):464-478. PMID: 37142671 -
Bioact Mater
Dynamically responsive hydrogel with mechanical stimulation enhances diabetic wound healing via activation of Piezo1-mediated efferocytosis. [Abstract]2026 Feb 4:60:607-625. PMID: 41727270 -
-
ACS Nano
Anti-Triggering Receptor Expressed on Myeloid Cells 2-Conjugated Nanovesicles Loaded Vadimezan Reprogram Tumor-Associated Macrophages to Combat Recurrent Lung Cancer. [Abstract]2025 Aug 29. PMID: 40879116 -
ACS Nano
Morphology-Mediated Tumor Deep Penetration for Enhanced Near Infrared II Photothermal and Chemotherapy of Colorectal Cancer. [Abstract]2024 Oct 15;18(41):28038-28051. PMID: 39363419 -
Nat Commun
Triple targeting of STING, TGF-β, and PD-L1 boosts CXCL16-CXCR6 signaling for potent antitumor response. [Abstract]2026 Feb 9;17(1):1441. PMID: 41663428 -
Autophagy
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4. [Abstract]2021 Nov;17(11):3592-3606. PMID: 33629929 -
Theranostics
Dabigatran activates inflammation resolution by promoting fibrinogen-like protein 2 shedding and RvD5n-3 DPA production. [Abstract]2021 Feb 20;11(9):4251-4261. PMID: 33754059
CFDA-SE purchased from MedChemExpress. Usage Cited in: Theranostics. 2021 Feb 20;11(9):4251-4261. [Abstract]
After mouse BMDMs were pretreated with PBS (control; CON), heparin (HEP, 3 U/mL), warfarin (WAR, 100 ng/mL), dabigatran (DAB, 100 ng/mL), TMI-1 (10 µM), and baicalein (Bai, 10 µM) for 4 h, they were co-cultured with CFDA-SE (CFSE, 1 μM; 30 min)-labeled apoptotic MC38 cells at the ratio of 1:10 for 30 min, efferocytosis was performed with flow cytometry.
-
J Adv Res
Mitochondrial fatty acid oxidation as the target for blocking therapy-resistance and inhibiting tumor recurrence: The proof-of-principle model demonstrated for ovarian cancer cells. [Abstract]2025 Mar 17:S2090-1232(25)00186-9. PMID: 40107354 -
Biomaterials
Engineered low-pathogenic Helicobacter pylori as orally tumor immunomodulators for the stimulation of systemic immune response. [Abstract]2024 Dec:311:122672. PMID: 38897029 -
Small
Nanoadjuvant-Mediated EV-Derived Artificial APC to Trigger Protective Immunity Against Virus Infection. [Abstract]2025 Aug 13:e01291. PMID: 40801246 -
Gut Microbes
Weizmannia coagulans BCF-01: a novel gastrogenic probiotic for Helicobacter pylori infection control. [Abstract]2024 Jan-Dec;16(1):2313770. PMID: 38334087 -
Gut Microbes
Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell. [Abstract]2023 Dec;15(2):2249143. PMID: 37635362 -
Cell Rep Med
scRNA-seq reveals an immune microenvironment and JUN-mediated NK cell exhaustion in relapsed T-ALL. [Abstract]2025 Apr 25:102098. PMID: 40306275 -
J Immunother Cancer
Tumor-intrinsic TTLL12 drives resistance to cancer immunotherapy via modulating myeloid-derived suppressor cells. [Abstract]2025 Jun 3;13(6):e010873. PMID: 40461158 -
Cell Rep Med
Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia. [Abstract]2024 May 16:101580. PMID: 38776913 -
Pharmacol Res
PAR2 deficiency impairs antitumor immunity and attenuates anti-PD1 efficacy in colorectal cancer. [Abstract]2025 Mar 31:107721. PMID: 40174816 -
Cancer Lett
Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization. [Abstract]2024 Apr 10:587:216732. PMID: 38360142 -
Cancer Lett
Myeloid-derived suppressor cells deficient in cholesterol biosynthesis promote tumor immune evasion. [Abstract]2023 Jun 28:564:216208. PMID: 37150500 -
Cancer Lett
MiR-26b-5p in small extracellular vesicles derived from dying tumor cells after irradiation enhances the metastasis promoting microenvironment in esophageal squamous cell carcinoma. [Abstract]2022 Aug 10:541:215746. PMID: 35594995
CFDA-SE purchased from MedChemExpress. Usage Cited in: Cancer Lett. 2022 Aug 10:541:215746. [Abstract]
PBMCs are labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) (2.5 μM). The proliferation of T cells is assessed by CFSE intensity using flow cytometry.
-
Acta Biomater
IL-21R-Targeted Nano-immunosuppressant Prevents Acute Rejection in Allogeneic Transplantation by Blocking Maturation of T Follicular Helper Cells. [Abstract]2025 Jun 1:199:346-360. PMID: 40339970 -
Cell Death Dis
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis. [Abstract]2025 May 14;16(1):380. PMID: 40368918 -
Cell Death Dis
MAPK4 inhibits the early aberrant activation of B cells in rheumatoid arthritis by promoting the IRF4-SHIP1 signaling pathway. [Abstract]2025 Jan 26;16(1):43. PMID: 39863600 -
Proc Natl Acad Sci U S A
2022 Aug 9;119(32):e2201899119. PMID: 35914155
CFDA-SE purchased from MedChemExpress. Usage Cited in: Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2201899119. [Abstract]
Representative images of CFDA-SE (CFSE)-based proliferation assay of CD4+ T cells cocultured with AT2 cells from healthy, LLC-bearing GPX3fl/fl, or GPX3cKO mice respectively.
-
J Pharm Anal
Secondary metabolites of mulberry leaves exert anti-lung cancer activity through regulating the PD-L1/PD-1 signaling pathway. [Abstract]2024 Jun;14(6):100926. PMID: 38974523 -
Dev Cell
Vimentin intermediate filaments coordinate actin stress fibers and podosomes to determine the extracellular matrix degradation by macrophages. [Abstract]2025 Jun 23;60(12):1669-1685.e6. PMID: 39952241 -
Int J Biol Macromol
Targeted gene delivery of shear-responsive forkhead box C1 using hyaluronic acid modified chitosan nanoparticles suppresses atherosclerosis through Hippo-YAP signaling pathway. [Abstract]2025 Oct 14;330(Pt 4):148307. PMID: 41101410 -
Int J Biol Macromol
The recombinant vaccine of Lactobacillus plantarum elicits immune protection against H1N1 and H9N2 influenza virus infection. [Abstract]2024 Aug;275(Pt 1):133453. PMID: 38942402 -
Phytomedicine
Tetrastigma hemsleyanum polysaccharides as natural inhibitors of platelet thrombosis via GPIIb/IIIa and MAPK pathways. [Abstract]2025 Oct 21:148:157439. PMID: 41175575 -
Free Radic Biol Med
Oxidative stress impairs the expansion of regulatory T cells in active vitiligo via dysregulated CGRP-RAMP1-Gαi3 signaling. [Abstract]2025 Dec 24:245:18-29. PMID: 41453541 -
J Transl Med
The surface protein Gbp of Fusobacterium nucleatum inhibits osteogenic differentiation by inactivating the Wnt/β-catenin pathway via binding to Annexin A2. [Abstract]2025 May 14;23(1):540. PMID: 40369630 -
Oncogene
ASCL2 induces an immune excluded microenvironment by activating cancer-associated fibroblasts in microsatellite stable colorectal cancer. [Abstract]2023 Sep;42(38):2841-2853. PMID: 37591954 -
J Med Chem
Novel Indoleamine-2,3-Dioxygenase-Targeted Pt(IV) Prodrugs Regulate the Tumor Immune Microenvironment to Achieve Chemoimmunotherapy In Vitro and In Vivo. [Abstract]2025 Feb 27;68(4):4352-4372. PMID: 39918588 -
Neural Regen Res
Small extracellular vesicles from hypoxia-preconditioned bone marrow mesenchymal stem cells attenuate spinal cord injury via miR-146a-5p-mediated regulation of macrophage polarization. [Abstract]2024 Oct 1;19(10):2259-2269. PMID: 38488560 -
NPJ Vaccines
A KIF20A-based thermosensitive hydrogel vaccine effectively potentiates immune checkpoint blockade therapy for hepatocellular carcinoma. [Abstract]2025 Jan 3;10(1):1. PMID: 39753573 -
OncoImmunology
TNFSF15 facilitates differentiation and polarization of macrophages toward M1 phenotype to inhibit tumor growth. [Abstract]2022 Feb 1;11(1):2032918. PMID: 35127254
CFDA-SE purchased from MedChemExpress. Usage Cited in: OncoImmunology. 2022 Feb 1;11(1):2032918. [Abstract]
Flow cytometric analysis of the proliferation rates of bone marrow-derived CD11b+F4/80+ cells as the function of time being cultured in the presence and absence of TNFSF15. Bone marrow cells are incubated with 5 μM CFSE (CFDA-SE) for 10 min at 37°C.
-
J Agric Food Chem
Postbiotics Suppress Helicobacter pylori Adhesion and Survival through a Coaggregation Mechanism. [Abstract]2025 Sep 3;73(35):21976-21986. PMID: 40833828 -
J Agric Food Chem
A Disintegrin and Metalloproteinase 17 Disrupts Bovine Macrophage MER Proto-Oncogene Tyrosine Kinase Integrity to Impede Apoptotic Cell Clearance and Promote Inflammation in Clinical Mastitis. [Abstract]2025 Jan 8;73(1):549-561. PMID: 39731564 -
Eur J Med Chem
2025 May 29:295:117798. PMID: 40460724 -
Front Immunol
TSC1 Affects the Process of Renal Ischemia-Reperfusion Injury by Controlling Macrophage Polarization. [Abstract]2021 Mar 9;12:637335. PMID: 33767704 -
Chin Med
Proteomic antibacterial characterization of flavonoid xanthohumol and probiotic Clostridium butyricum on pathogenic Clostridioides difficile. [Abstract]2026 Feb 3;21(1):64. PMID: 41634763 -
Colloids Surf B Biointerfaces
Intranasal delivery of temozolomide and disulfiram in situ gel combined with copper for enhanced glioblastoma therapy. [Abstract]2025 Jun 24:255:114898. PMID: 40592114 -
Biochem Pharmacol
A non-bactericidal glycine-rich peptide enhances cutaneous wound healing in mice via the activation of the TLR4/MAPK/NF-κB pathway. [Abstract]2025 Mar 29:116912. PMID: 40164342 -
J Ethnopharmacol
Anti-tumor effect of flavonoids isolated from Bidens Pilosa L. by regulating the activity of myeloid-derived suppressor cells within the tumor microenvironment in mice. [Abstract]2025 Sep 23;355(Pt A):120635. PMID: 40998135 -
Cells
Regulation of the Homeostasis of Early Embryo Development in Dairy Cows by Targeted Editing of the PRLR Gene-Mediated Activation of the Anti-Heat Stress Pathway. [Abstract]2025 Nov 25;14(23):1856. PMID: 41369349 -
Int J Pharm
Surface functionalization of virus-like particles via bioorthogonal click reactions for enhanced cell-specific targeting. [Abstract]2024 Jun 10:124332. PMID: 38866085 -
Int J Pharm
Hypoxia-sensitive adjuvant loaded liposomes enhance the antimicrobial activity of azithromycin via phospholipase-triggered releasing for Pseudomonas aeruginosa biofilms eradication. [Abstract]2022 Jul 25:623:121910. PMID: 35710071 -
Liver Int
Deficiency of canonical Wnt/β-catenin signalling in hepatic dendritic cells triggers autoimmune hepatitis. [Abstract]2020 Jan;40(1):131-140. PMID: 31505100 -
-
Commun Biol
A spike-targeting bispecific T cell engager strategy provides dual layer protection against SARS-CoV-2 infection in vivo. [Abstract]2023 Jun 1;6(1):592. PMID: 37264086 -
Life Sci
Ultrasound targeting of microbubble-bound anti PD-L1 mAb to enhance anti-tumor effect of cisplatin in cervical cancer xenografts treatment. [Abstract]2020 Dec 1;262:118565. PMID: 33038371 -
PLoS Pathog
CD28-deficient mice are vulnerable to mouse papillomavirus MmuPV1 infection of the skin and mucosae. [Abstract]2026 Mar 10;22(3):e1013968. PMID: 41805718 -
Front Pharmacol
Hypoxic-preconditioned mesenchymal stem cell-derived small extracellular vesicles inhibit neuronal death after spinal cord injury by regulating the SIRT1/Nrf2/HO-1 pathway. [Abstract]2024 Aug 23:15:1419390. PMID: 39246654 -
Pharm Biol
Lucialdehyde B suppresses proliferation and induces mitochondria-dependent apoptosis in nasopharyngeal carcinoma CNE2 cells. [Abstract]2023 Dec;61(1):918-926. PMID: 37323017 -
Pharmaceuticals
2022 Aug 26;15(9):1059. PMID: 36145280 -
Pharmaceuticals (Basel)
Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and Recruitment. [Abstract]2022 Mar 10;15(3):338. PMID: 35337136 -
Front Bioeng Biotechnol
Preparation of Fucoidan-Based Electrospun Nanofibers and Their Interaction With Endothelial Cells. [Abstract]2021 Sep 6;9:739209. PMID: 34552917 -
Cell Oncol (Dordr)
Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression. [Abstract]2020 Dec;43(6):1099-1116. PMID: 32710433 -
Int Immunopharmacol
2026 May 15:177:116529. PMID: 41871492 -
Int Immunopharmacol
Isolinderalactone attenuates atherosclerosis through inhibiting NF-κB-mediated inflammation in macrophages. [Abstract]2025 Nov 17;168(Pt 2):115848. PMID: 41252771 -
Int Immunopharmacol
Aβ impairs bone vascular homeostasis in APP/PS1 mice via disrupting the mitochondrial fission-efferocytosis axis in macrophages. [Abstract]2025 Sep 10:165:115526. PMID: 40934542 -
Int Immunopharmacol
Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target. [Abstract]2025 May 15:158:114835. PMID: 40378432 -
Int Immunopharmacol
Morin hydrate inhibits atherosclerosis and LPS-induced endothelial cells inflammatory responses by modulating the NFκB signaling-mediated autophagy. [Abstract]2021 Nov:100:108096. PMID: 34464886 -
Mol Ther Methods Clin Dev
Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection. [Abstract]2021 Jun 11:21:754-764. PMID: 34007862 -
RSC Adv
2020 Apr 6;10(23):13848-13854. PMID: 35492981 -
Cancer Biol Ther
A novel targeted GPC3/CD3 bispecific antibody for the treatment hepatocellular carcinoma. [Abstract]2020 Jul 2;21(7):597-603. PMID: 32240054 -
Hepatobiliary Pancreat Dis Int
Translationally controlled tumor protein exerts a proinflammatory role in acute rejection after liver transplantation. [Abstract]2020 Jun;19(3):235-243. PMID: 32224126 -
Eur J Pharm Biopharm
Nanobubble-mediated Co-delivery of Ce6 and miR-195 for Synergized Sonodynamic and Checkpoint Blockade Combination Therapy with Elicitation of Robust Immune Response in Hepatocellular Carcinoma. [Abstract]2022 Dec:181:36-48. PMID: 36307001 -
Front Cell Dev Biol
2022 Apr 20;10:889656. PMID: 35517499 -
FEBS J
LC3-positive extracellular vesicles released from tumor cells promote lung metastasis of breast cancer by inducing vascular permeability. [Abstract]2025 Nov 27. PMID: 41307630 -
Mol Nutr Food Res
Effect of Lactobacillus rhamnosus MN-431 Producing Indole Derivatives on Complementary Feeding-Induced Diarrhea Rat Pups Through the Enhancement of the Intestinal Barrier Function. [Abstract]2022 Jan;66(2):e2100619. PMID: 34806832
CFDA-SE purchased from MedChemExpress. Usage Cited in: Mol Nutr Food Res. 2022 Jan;66(2):e2100619. [Abstract]
CFDA-SE (10 μM) was added to bacterial suspension and then incubated at 37°C in the dark for 20 min. The four strains were labeled with fluorescent probe CFDA-SE and were gavaged to baby rats to evaluate their colonization ability. Compared to the control group, the CFDA-SE fluorescence was present in rats gavaged with the four strains.
-
J Cell Mol Med
Expression profiles and potential roles of transfer RNA-derived small RNAs in atherosclerosis. [Abstract]2021 Jul;25(14):7052-7065. PMID: 34137159 -
J Cell Mol Med
Prostaglandin E3 attenuates macrophage-associated inflammation and prostate tumour growth by modulating polarization. [Abstract]2021 Jun;25(12):5586-5601. PMID: 33982835 -
J Inflamm Res
Qing-Luo-Yin Eases T Cells-Mediated Angiogenesis in Adjuvant-Induced Arthritis Rats by Activating PPARγ. [Abstract]2025 Mar 10:18:3469-3484. PMID: 40093952 -
Transl Oncol
Individualized tumor-reactive T cells exhibit a potent anti-tumor response in prostate cancer. [Abstract]2025 Apr:54:102322. PMID: 39986192 -
iScience
CircTMEM165 facilitates endothelial repair by modulating mitochondrial fission via miR-192/SCP2 in vitro and in vivo. [Abstract]2024 Mar 16;27(4):109502. PMID: 38591009 -
Transl Oncol
Silencing of PD-1 combined with EBV-specific killer T cells for the treatment of EBV-associated B lymphoma. [Abstract]2024 Feb:40:101831. PMID: 38039947 -
iScience
Crosstalk between integrin/FAK and Crk/Vps25 governs invasion of bovine mammary epithelial cells by S. agalactiae. [Abstract]2023 Sep 9;26(10):107884. PMID: 37766995 -
iScience
Chidamide suppresses adipogenic differentiation of bone marrow derived mesenchymal stem cells via increasing REEP2 expression. [Abstract]2023 Feb 16;26(3):106221. PMID: 36879811 -
Sci Rep
HIIT and MICT mitigate endothelial dysfunction in early atherosclerotic mice via PCSK9 inhibition. [Abstract]2025 Aug 19;15(1):30411. PMID: 40830352 -
ACS Infect Dis
A Frog-Derived Cathelicidin Peptide with Dual Antimicrobial and Immunomodulatory Activities Effectively Ameliorates Staphylococcus aureus-Induced Peritonitis in Mice. [Abstract]2022 Dec 9;8(12):2464-2479. PMID: 36378028 -
Mol Cell Biochem
RNF125 promotes CD8 T cell-mediated anticancer immunity and suppresses the malignant phenotype of cervical cancer. [Abstract]2026 Mar 13. PMID: 41824200 -
Heliyon
The roles and molecular mechanisms of long non-coding RNA WT1-AS in the maintenance and development of gastric cancer stem cells. [Abstract]2023 Mar 21;9(4):e14655. PMID: 37025896 -
Microb Pathog
Covalent sortase A inhibitor, α, β-unsaturated aldehydes, prevents Staphylococcus aureus infection. [Abstract]2025 Mar 21:107472. PMID: 40122408 -
Vaccines
2025 Mar 19;13(3):324. PMID: 40266219 -
BMC Cancer
Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells. [Abstract]2021 Oct 13;21(1):1101. PMID: 34645397 -
Cytotherapy
NLRC5 knockdown in CD4+CD25+ Treg cells attenuates cardiac allograft rejection through enhanced immunosuppressive function. [Abstract]2025 Dec;27(12):1419-1426. PMID: 41085514 -
J Leukoc Biol
Transient receptor potential vanilloid 4 (TRPV4) in neutrophils enhances myocardial ischemia/reperfusion injury. [Abstract]2023 Sep 1;114(3):266-279. PMID: 37232941 -
Immunopharmacol Immunotoxicol
In vitro impact of bisphenol A on maturation and function of monocyte-derived dendritic cells in patients with primary Sjögren's syndrome. [Abstract]2020 Feb;42(1):28-36. PMID: 31876196 -
J Cancer Res Clin Oncol
The crosstalk between lung cancer cells and platelets promotes tumor angiogenesis in vivo and in vitro. [Abstract]2023 Jul;149(7):3495-3511. PMID: 35951091 -
Ther Adv Chronic Dis
Serum-derived exosomes containing NEAT1 promote the occurrence of rheumatoid arthritis through regulation of miR-144-3p/ROCK2 axis. [Abstract]2021 Apr 27:12:2040622321991705. PMID: 33995991 -
Animals (Basel)
Development of a Mucosal Immune-Enhancing Oral Vaccine Candidate Against Porcine Epidemic Diarrhea Virus Using Lactobacillus paracasei. [Abstract]2026 Feb 3;16(3):471. PMID: 41681452 -
Cent Eur J Immunol
Generation of high cross-presentation ability human dendritic cells by combination of interleukin 4, interferon β and GM-CSF. [Abstract]2022;47(2):125-138. PMID: 36751394 -
-
-
-
-
-
-
-
Dis Markers
Study on the Killing Effect of γδ T Cells Activated by Rukangyin on Breast Cancer MDA-MB-231 Cells. [Abstract]2021 Oct 15;2021:5838582. PMID: 34691287 -
Solvent & Solubility
DMSO : 50 mg/mL (89.69 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocol
Single-cell suspensions of splenocytes (or PBMC) are stained with 1 µM CFSE in PBS for 9 min at 37°C, combined with 20 mL of 10% FBS RPMI-1640 medium at RT for 2 min, centrifuged, washed, and counted. 2×106 CFSE-labeling splenocytes are added to the top of the slices in 24-well membrane culture insert[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
-
Data Sheet (278 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Banks HT, et al. Quantifying CFSE Label Decay in Flow Cytometry Data. Appl Math Lett. 2013 May 1;26(5):571-577. [Content Brief]
[2]. A Bruce Lyons, et al. Flow cytometric analysis of cell division by dilution of CFSE and related dyes. Curr Protoc Cytom. 2013;Chapter 9:Unit9.11. [Content Brief]
[3]. Cui J, et al. Prostaglandin E3 attenuates macrophage-associated inflammation and prostate tumour growth by modulating polarization. J Cell Mol Med. 2021 Jun;25(12):5586-5601. [Content Brief]
[4]. Xiuyun Jiang et al. Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment. Oncoimmunology. 2017; 6(7): e1333210. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.7939 mL | 8.9693 mL | 17.9385 mL | 44.8463 mL |
| 5 mM | 0.3588 mL | 1.7939 mL | 3.5877 mL | 8.9693 mL | |
| 10 mM | 0.1794 mL | 0.8969 mL | 1.7939 mL | 4.4846 mL | |
| 15 mM | 0.1196 mL | 0.5980 mL | 1.1959 mL | 2.9898 mL | |
| 20 mM | 0.0897 mL | 0.4485 mL | 0.8969 mL | 2.2423 mL | |
| 25 mM | 0.0718 mL | 0.3588 mL | 0.7175 mL | 1.7939 mL | |
| 30 mM | 0.0598 mL | 0.2990 mL | 0.5980 mL | 1.4949 mL | |
| 40 mM | 0.0448 mL | 0.2242 mL | 0.4485 mL | 1.1212 mL | |
| 50 mM | 0.0359 mL | 0.1794 mL | 0.3588 mL | 0.8969 mL | |
| 60 mM | 0.0299 mL | 0.1495 mL | 0.2990 mL | 0.7474 mL | |
| 80 mM | 0.0224 mL | 0.1121 mL | 0.2242 mL | 0.5606 mL |